Anti-cancer T-cells pass trials with flying colours

Anti-cancer T-cells pass trials with flying colours

Anti-cancer T-cells pass trials with flying colours. A therapy using modified immune cells is showing promise but still poses risks. Viviane Richter reports. T lymphocytes, or T-cells, (in yellow) attack a cancer cell in this coloured scanning electron

(Visited 1 times, 1 visits today)
2
Like
Save

Comments

Comments are disabled for this post.